drugset / Trial / NCT00370318

Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

NCT00370318 ↗

Phase 3 Completed 400 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this trial is to assess if the rate of febrile reactions following the co-administration of pneumococcal conjugate vaccines with standard infant vaccines is lowered when paracetamol is given prophylactically.

Timeline

Start
2006-09
Primary completion
—
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule — —
Background 10-valent pneumococcal conjugate vaccine Vaccine — —
Background Infanrix hexa Vaccine — —
Background Rotarix Vaccine — —

Indications